We recognize that there is a reduction in GLT1/EAAT2 and Kir4.1 expression in the striatum in other mHTT-expressing mouse models (Liévens et al., 2001; Tong et al., 2014; Khakh et al., 2017), and increased GFAP expression in the HD lentiviral mouse model (Faideau et al., 2010; Wu et al., 2020). Here, SLC1A2 is linked to Huntington disease.